Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy T Batchelor

Showing results (171-180 of 268) with videos related to

Pageof 27
Sort By:
NMR in Biomedicine|October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B<sub>0</sub> -shim array coils at 3 TBernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2019
Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade gliomaShervin Tabrizi, Beow Y Yeap, Janet C Sherman, et al.
The Oncologist|February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic ControlChristopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.
Cancer Research|April 3, 2003
Gene expression-based classification of malignant gliomas correlates better with survival than histological classificationCatherine L Nutt, D R Mani, Rebecca A Betensky, et al.
Neuro-Oncology Practice|October 5, 2020
Perceptions of prognosis and goal of treatment in patients with malignant gliomas and their caregiversDeborah A Forst, Kit Quain, Sophia L Landay, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Radiology. Artificial Intelligence|January 10, 2024
Expert-centered Evaluation of Deep Learning Algorithms for Brain Tumor SegmentationKatharina V Hoebel, Christopher P Bridge, Sara Ahmed, et al.
Cancer Research|January 5, 2011
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escapeEmmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, et al.
Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Pageof 27

Showing results (171-180 of 268) with videos related to

Sort By:
Pageof 27
NMR in Biomedicine|October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B<sub>0</sub> -shim array coils at 3 TBernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2019
Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade gliomaShervin Tabrizi, Beow Y Yeap, Janet C Sherman, et al.
The Oncologist|February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic ControlChristopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.
Cancer Research|April 3, 2003
Gene expression-based classification of malignant gliomas correlates better with survival than histological classificationCatherine L Nutt, D R Mani, Rebecca A Betensky, et al.
Neuro-Oncology Practice|October 5, 2020
Perceptions of prognosis and goal of treatment in patients with malignant gliomas and their caregiversDeborah A Forst, Kit Quain, Sophia L Landay, et al.
Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Radiology. Artificial Intelligence|January 10, 2024
Expert-centered Evaluation of Deep Learning Algorithms for Brain Tumor SegmentationKatharina V Hoebel, Christopher P Bridge, Sara Ahmed, et al.
Cancer Research|January 5, 2011
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escapeEmmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, et al.
Annals of Neurology|April 6, 2006
International study on low-grade primary central nervous system lymphomaKristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Pageof 27